Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer

Original Article

Y.-L. Wu, R. Dziadziuszko, J.S. Ahn, F. Barlesi, M. Nishio, D.H. Lee, J.-S. Lee, W. Zhong, H. Horinouchi, W. Mao, M. Hochmair, F.d. Marinis, M.R. Migliorino, I. Bondarenko, S. Lu, Q. Wang, T.O. Lohmann, T. Xu, A. Cardona, T. Ruf, J. Noe, and B.J. Solomon

N Engl J Med 2024;390:1265-1276

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
04/10/2024
Course expires: 
04/11/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.